header
Image from OpenLibrary

A retrospective comparative study evaluating the incidence and severity of chronic graft - versus - host disease in myeloablative and nonmyeloablative allogeneic hematopoietic stem cell transplantation / Marwa Mohammed Nabil Samy ; Supervised Magda Ramzy , Omar Abdelrahman Fahmy

By: Contributor(s): Language: Eng Publication details: Cairo : Marwa Mohammed Nabil Samy , 2004Description: 215P. : charts ; 25cmOther title:
  • دراسة مقارنة لتقييم معدل حدوث وشدة الطرد العكسى المزمن فى كل من زراعة النخاع العظمى الكلى وزراعة النخاع العظمى منخفض الكثافة [Added title page title]
Subject(s): Available additional physical forms:
  • Issued also as CD
Dissertation note: Thesis (M.Sc.) - Cairo University - Faculty Of Medicine - Department Of Internal Medicine Summary: Results of our study showed no significant difference either in incidence or severity of cGvHD between both groups.These results were consistent with a study done by mielcarek et al , on 44 patients who underwent nonmyeloablative HSCT compared to 52 underwent myeloablative HSCT median ages , 56 and 54 years respectively
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Home library Call number Status Date due Barcode
Thesis Thesis قاعة الرسائل الجامعية - الدور الاول المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.18.M.Sc.2004.Ma.R (Browse shelf(Opens below)) Not for loan 01010110048318000
CD - Rom CD - Rom مخـــزن الرســائل الجـــامعية - البدروم المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.18.M.Sc.2004.Ma.R (Browse shelf(Opens below)) Not for loan 01020110048318000

Thesis (M.Sc.) - Cairo University - Faculty Of Medicine - Department Of Internal Medicine

Results of our study showed no significant difference either in incidence or severity of cGvHD between both groups.These results were consistent with a study done by mielcarek et al , on 44 patients who underwent nonmyeloablative HSCT compared to 52 underwent myeloablative HSCT median ages , 56 and 54 years respectively

Issued also as CD

There are no comments on this title.

to post a comment.